Imagio® OA/US Breast Imaging System (#9005)
Imagio® OA/US Breast Imaging System (#9100)
Imagio® Breast Imaging System Virtual Patent Marking
Seno Medical Instruments Inc. is leading the way in cancer diagnosis with the revolutionary Imagio® device. The Imagio® system's breakthrough functional imaging modality makes use of patented opto-acoustic technology.
This page is intended to serve as notice under 35 U.S.C. § 287(a).
The Imagio® Breast Imaging System is protected by the following patents:
United States of America: 11,660,003; 10,026,170; 10,251,561; 10,278,589; 10,285,595; 10,321,896; 10,327,647; 10,349,921; 10,354,379; 10,436,705; 10,433,732; 10,517,481; 10,638,935; 10,709,419; 10,762,628; 10,949,967; 11,382,565; 8,686,335; 8,823,928; 9,163,980; 9,282,899; 9,289,191; 9,330,452; 9,398,893; 9,445,785; 9,445,786; 9,456,805; 9,517,055; 9,528,936; 9,610,043; 9,724,072; 9,733,119; 9,743,839; 9,792,686; 9,814,394; 9,836,838; Patents Pending: 16/197,762; 17/647,565; 17/661,784; 17/814,083; 17/387,743; 18/296,743; 18/475,948
Australia: 2,012,332,233; 2,012,332,304; 2,013,229,748; 2,013,274,136; 2,013,274,138; 2,014,209,521; 2,018,201,462
Canada: 2,851,624; 2,874,878; 2,861,089; 2,899,007; 2,902,056; 2,902,161; 2,947,734
European Patent Office: 2,766,851; 2,773,268; 2,948,064; 2,967,486; 3,136,952; Patents Pending: 16/197,762; 17/647,565; 17/661,784; 17/814,083; 17/387,743; 18/296,743; 18/475,948
Japan: 6,732,830; 6,505,919; 7,013,437; 6,172,719; 6,239,604; 6,313,412; 6,322,578; 6,391,593; 6,479,471; 6,509,893; 6,600,717; 6,732,709; 6,743,202; Patents Pending: PCT/US2019/053087
Republic of Korea: 2,090,840; 2,105,724; 2,105,728; 2,117,132; 2,148,540; 2,170,350; 2,226,374
China: Patents Pending: CN 113194815A
The SenoGram® Artificial Intelligence Tool is protected by the following patents:
United States of America: 11,246,527; 10,542,892